International Clinical Trial: First-in-Human Evaluation of [11C]JMJ-129-d2 for PDE-4D Imaging in Healthy Volunteers

Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07853781) titled 'First-in-Human Evaluation of [11C]JMJ-129-d2 for PDE-4D Imaging in Healthy Volunteers' on Oct. 1.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).

Primary Sponsor: National Institute of Mental Health (NIMH)

Condition: Healthy

Intervention: Drug: [11C]JMJ-129-d2

Recruitment Status: Recruiting

Phase: Phase 1

Date of First Enrollment: October 26, 2026

Target Sample Size: 40

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07853781

Disclaimer: Curate...